Surfactant
SURFACTANT
- Soap-like substance secreted by type-II pneumocytes of alveolar epithelium
- Major role in maintaining the lung compliance.
Embryological facts on surfactant:
- Surfactant synthesis occurs in 24 – 28th week of gestation
- Amniotic fluid appearance in 28 – 32nd week.
- Pre-term conditions – Deduction in 28th week.
- Mature levels of surfactant after 35th week
Composition:
- Surface-active lipoprotein complex (phospho-lipo-protein)
- Main surface tension lowering phospholipid in surfactant
- Dipalmitoyl-phosphatidylcholine (DPPC) (dipalmitoyl-lecithin)
Other substances present include:
- Phosphatidylglycerol
- Neutral lipids
- 4 Surfactant proteins (SP – (A to D)
- Carbohydrates
- Other phospholipids.
Mechanism of action:
- Breaking water molecule inside alveoli:
- Water molecule lining alveoli exert elastic contractile force
- Resulting in alveolar collapse
- Surfactant breaks this surface tensional force of water molecules.
Functions:
- Acts on alveoli
- Reduces surface tension of fluid-lined alveoli
- Prevents lung and alveolar collapse
- Increases lung compliance
- Prevents pulmonary edema
Special physiological effects:
- Reduction in alveolar surface tension.
- Reduces collapsing tendency of alveoli & lungs.
Alveolar stabilization:
- Is a property of alveoli to reduce natural tendency of smaller alveoli to collapse into larger ones.
- Also, reduces tendency of alveolar interstitial fluid transuding out to alveolar space
- Reduces alveolar elastic recoil.
Effects of surfactant deficiency:
- Decreased compliance
- Increased elastic recoil
- Hyaline membrane formation
- Atelectasis
- Interstitial edema
Conditions associated with surfactant:
1. Acute Infant Respiratory Distress Syndrome (IRDS)
- Also referred “Hyaline membrane Disease” (HMD)
- In premature infants
- Glucocorticoids accelerate surfactant production in premature lungs
Cause:
- Due to Immature functional surfactant system
- Insufficient production of surfactant dipalmitoyl lecithin
Treatment:
- Corticosteroid administration to pregnant women.
- Transplacental transport to fetus promote,
- Accelerated fetal lung maturation.
- Production of surfactant.
2. Cigarette smoking:
- Decreased surfactant
Exam Question
SURFACTANT
- Soap like substance secreted by type-II pneumocytes of alveolar epithelium
Embryological factors of surfactant:
- Surfactant synthesis occurs in 24 – 28th week of gestation
- Amniotic fluid appearance in 28 – 32nd week.
- Pre-term conditions – Deduction in 28th week.
- Mature levels of surfactant after 35th week.
Composition:
- Surface-active lipoprotein complex (phospho-lipo-protein)
- Main surface tension lowering phospholipid in surfactant
- Dipalmitoyl-phosphatidylcholine (DPPC) (dipalmitoyl-lecithin
Mechanism of action:
- Breaking water molecule inside alveoli
- Surfactant breaks surface tensional force of water molecules.
Functions:
- Acts on alveoli
- Reduces surface tension of fluid-lined alveoli
- Increases lung compliance
Special physiological effects:
- Reduction in alveolar surface tension.
- Alveolar stabilization:
- Is a property of alveoli to reduce the natural tendency of smaller alveoli to collapse into larger ones.
Effects of surfactant deficiency:
- Decreased compliance.
- Hyaline membrane formation.
Conditions associated with surfactant:
1. Acute Infant Respiratory Distress Syndrome (IRDS)
- Also referred “Hyaline membrane Disease” (HMD).
- In premature infants.
- Glucocorticoids accelerate surfactant production in premature lungs.
Cause:
- Due to Immature functional surfactant system
- Insufficient production of surfactant dipalmitoyl lecithin
Treatment:
- Corticosteroid administration to pregnant women.
- Promote accelerated fetal lung maturation.
- Production of surfactant.
2. Cigarette smoking:
- Decreased surfactant
Don’t Forget to Solve all the previous Year Question asked on Surfactant


